Gupta Rishi
Enliven Therapeutics, Inc. · Director
Gupta Rishi is listed in public filings as director. This Gupta Rishi insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN), and Turnstone Biologics Corp. (TSBX). Investors use Gupta Rishi's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $923k34k shares | Grant / ExerciseFeb 12, 2026 | $923.1K34k shares | $27.16 | -- | |
| $43k1.6k shares | Grant / ExerciseFeb 12, 2026 | $42.9K1.6k shares | $27.16 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $03.1M shares | OtherAug 8, 2025 | $1.1M3.1M shares | $0.34 | -- | |
| $460k20.5k shares | Grant / ExerciseFeb 6, 2025 | $460.4K20.5k shares | $22.47 | -- |